SONUINFRA.NS,0P0001OXUR,0
SONUINFRA · General/Diversified · NSE
₹76
Current Market Price
Fair Value (DCF)
₹133
Margin of Safety
+75.6%
Updated 6h ago
YieldIQ Score
70/100
Piotroski F-Score
3/9
Economic Moat
Narrow
Confidence
15%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹79 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
—
Short-term liquidity
Asset Turnover
0.94×
Revenue per ₹ of assets
Revenue CAGR (3Y)
47.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹76
Bear case
₹70.25
MoS -8.2%
Base case
₹133.49
MoS +43.1%
Bull case
₹181.57
MoS +58.1%
Ratio Trends
Historical ratio trends for SONUINFRA are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.
Historical Financials
Historical financials for SONUINFRA are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.
Peer Comparison
Peers not yet ranked for SONUINFRA. Comparable companies and side-by-side valuation will appear here once the peer set is established.
Dividend History
No dividend events recorded for SONUINFRA in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SONUINFRA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SONUINFRA →
Compare
Head-to-head with peers
Compare SONUINFRA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SONUINFRANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.